Recently we identi®ed a novel gene, gml, whose expression is regulated in a p53-dependent manner and found that gml expression was correlated with the sensitivity of esophageal cancer cells to anticancer drugs. To further investigate the biological mechanism of gml in determining the chemosensitivity of cancer cells to clinically useful agents, we introduced gml cDNA into TE10, an esophageal cancer cell line that lacks endogenous gml expression. In two resulting stable cell lines which expressed gml cDNA in the absence of wildtype p53, cell death occurred within 6 h after treatment with Taxol. TE10 parent cells or TE10 cells transfected with vector alone displayed relative resistance for 36 h. Induction of gml did not by itself aect viability. Morphological analysis con®rmed that the increased chemosensitivity to Taxol conferred by gml was due to apoptosis. These data suggest that reduced expression of gml is likely to be associated with poor response rates to chemotherapy, and that an assay for gml expression might serve a clinical purpose as a predictor of chemotherapeutic sensitivity.
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Keywords: p53; gml; apoptosis; chemosensitivity In vitro and clinical studies have demonstrated increased resistance to cell death in p53-null or p53-mutated cells following damage to DNA by irradiation or anticancer agents. Cells lacking wild-type p53 probably are unable to initiate apoptosis, or they suer delays in this process (Clarke et al., 1993; Lee and Bernstein 1993; Lowe et al., 1993a, b) . p53 appears to regulate downstream genes by binding to a speci®c consensus sequence of nucleotides, and the p53-targets are assumed to play sign®cant roles in modulating or mediating cell-cycle control, apoptosis, or DNA repair. These assumptions are consistent with studies linking inactivation of p53 with resistance to anticancer agents. Recently we identi®ed a novel gene, gml that was inducible by wild-type p53 (Furuhata et al., 1996) . In addition, we demonstrated an apparent correlation between expression of gml and sensitivity of esophageal cancer cells to several anticancer drugs, while no correlation was observed between p21 expression and drug sensitivity. Those results suggested that the gml gene product might play an important role in control of the cell cycle and/or the apoptotic pathway induced by wild-type p53 after DNA damage.
To further investigate the role of gml in drug-induced apoptosis, we examined gml expression for a possible correlation with sensitivity to Taxol. This drug does not damage DNA; instead, it stabilizes polymerization of tubulin, and the result is cell-cycle arrest in mitosis and apoptotic cell death (Schi and Horwitz, 1980; Donaldson et al., 1994) . Taxol has some ecacy in the treatment of ovarian and metastatic breast cancers, small-cell carcinomas of the lung, and malignant melanomas (Gregory and Delisa, 1993; Rowinski et al., 1990; Slichenmyer et al., 1991) , and some reports have suggested a correlation between p53 status and sensitivity to Taxol in these types of cancer cells (Wu et al., 1996; Delia et al., 1996) . Results of the study reported here indicate that gml expression is also likely to play a signi®cant role in Taxol-induced apoptosis.
A tetracycline-regulated system for expression of gml was introduced into an esophageal cancer cell line, TE10, that lacks endogenous gml expression because the p53 gene has been inactivated by chromosomal loss of one allele and a missense mutation in the other (Furuhata et al., 1996) . We established by G418 selection two stable cell lines that are able to express gml without wild-type p53. RT ± PCR analysis revealed that induction of gml in TE10-GML1 cells by withdrawal of doxycycline was greater by a factor of ten than that achieved in TE10-GML1 cells with doxycycline ( Figure 1 Figure 1 Inducible expression of gml. TE10-GML1 cells was cultured with (Dox+) or without (Dox7) 2 ng/ml of doxycycline. TE10 and TE10-vector cells were cultured without doxycycline. Total RNA was prepared from cells after 24 h incubation. Gene expression was determined by RT ± PCR analysis under semiquantitative conditions (Furuhata et al., 1996) . The integrity of the RNA template was controlled through ampli®cation of a GAPDH transcript which revealed similar signals in all samples induction in another cell line, TE10-GML2, was similar to that in TE10-GML1 cells (data not shown).
To investigate whether expression of the gml gene can in¯uence cell growth, we examined cell proliferation in culture media containing dierent concentrations of serum. TE10-GML1, its parent cell line (TE10), or a mock cell line (TE10-vector) which was transfected with the vector alone, all grew at almost the same rate in culture medium with 10% serum. However, in cultures containing only 0.5% serum, the growth rate of TE10-GML1 was suppressed significantly in comparison with the controls. For example, at day eight TE10-GML1 cells numbered fewer than 50% of the counts of TE10 or TE10-vector cells in 0.5% serum medium (Figure 2a,b) . The doubling times of TE10, TE10-vector, and TE10-GML1 under 0.5% serum were 48, 50 and 124 h, respectively. The distribution of cell-cycle phases was analysed with¯o w cytometry at 48 h after serum starvation; TE10-GML1 cells showed a higher percentage of G2/M phase than TE10 (28.3% vs 13.2%, respectively), whereas both cell lines showed about the same percentage of G1 (56.6% vs 54.9%, respectively) ( Figure 2c ). The phase distribution in TE10-vector cells was similar to that in TE10 cultures (data not shown). The observation that gml expression resulted in about a twofold increase of the G2/M population as compared to control cells (TE10 or TE10-vector) suggested a possible role of GML in arresting the cell cycle at G2/M.
We then examined the eect of gml expression on the sensitivity of cells to Taxol. The same cell lines used for the serum-starvation assay were continuously exposed to this drug. After the eective range of Taxol concentrations was determined by preliminary experiments (data not shown), we cultured the cell lines vector, displayed relative resistance 48 h after incubation (Figure 3b ). Analysis of TE10-GML1 cells continuously exposed to Taxol on¯ow cytometry revealed a decline in the G2/M peak coincident with the appearance of a sub-G1 population, characteristic of apoptotic cells, after 12 h of incubation. This sub-G1 population was increased strikingly at 24 h. Control cells showed relatively late transition into a sub-G1 population (Figure 3c ).
To investigate the morphological consequences of exposure to Taxol, we stained cells with DAPI to observe nuclear fragmentation. Cells were incubated at the same density as in the cell proliferation assay, and were continuously treated with 10 nM of Taxol. DAPI staining was performed at times 0, 6, 12 and 24 h during treatment. Typical apoptotic morphological changes, including nuclear condensation and fragmentation, were detected under¯uorescence microscopy Figure 3d ). Two independent clones, TE10-GML1 and TE10-GML2 showed greater incidence of apoptosis than control cells after 6-and 12-h exposures. The proportion of apoptotic cells increased in a timedependent manner (Figure 3e ). The results suggested that gml expression sensitized cells to Taxol by conferring a more immediate response to apoptosis, and that GML might play a signi®cant role, directly or indirectly, in transduction of apoptotic signals. It should be noted that in the presense of doxycyclin both the clones, TE10-GML1 and TE10-GML2, exhibited a basal level of gml expression and that Taxol-induced apoptosis was shown in these TE10-GML cell lines. As gml expression was still low in cells with wild-type p53 gene, low level of GML might be sucient for inducing apoptosis. We reported that the gml gene suppressed growth of esophageal-cancer cells that lacked wild-type p53 and endogenous gml expression, as indicated by an increased G2/M population under conditions of serum starvation. This result suggested that a role of GML protein might be transduction of signals for suppression of cell growth in autocrine/paracrine systems.
Since a number of dierent chemical agents can kill tumor cells by induction of apoptosis, it is conceivable that functional defects in apoptosis-regulating genes might be involved in resistance of cancer cells to anticancer agents. Correlation between p53 status and sensitivity to Taxol has not been ®rmly established. Con¯icting results have been reported thus far: Taxol has been reported to increase the levels of p53 in some cell types but not in others (Graniela et al., 1995; Tishler et al., 1995) . In an ovarian cancer cell line expressing wild-type p53, the disruption of p53 function led to a decrease in sensitivity to Taxol with a corresponding decrease in apoptosis induced by DNA-damaging agents (Wu and El-Deiry, 1996) . In contrast, in another ovarian cancer cell line not expressing p53, the introduction of a wild-type p53 did not change the sensitivity of these cells to Taxol (Graniela et al., 1995) . It has been reported that in human foreskin ®broblasts and mouse embryo fibroblast, the disruption of the wild-type p53 function resulted in an increased sensitivity of cells to Taxol treatment compared to cells expressing wild-type p53 (Wahl et al., 1996) .
We have shown here that gml expression in an esophageal cancer cell line correlates with sensitivity to the apoptotic stimuli conferred by Taxol. From these observations we derive the hypothesis that GML may be able to monitor the status of microtubules and transduce a signal to stimulate apoptosis; as such it cooperates with the eect of Taxol on the interphase cytoskeleton. GML would thus confer sensitization to anticancer agents by increasing G2/M arrest and apoptosis under`adverse' conditions such as Taxol treatment. Chemotherapy, in fact, often causes serious side-eects without having any eect on cancer cells, making the prognosis worse for a large proportion of patients with common solid tumors. However, it is still quite dicult to predict the ecacy of chemotherapy in advance. gml, a gene that is regulated speci®cally by p53, seems to be an important mediator of chemosensitivity. Therefore GML may possess potential clinical value both as a predictor of chemotherapeutic sensitivity and as an agent for gene therapy.
Materials and methods

Introduction of gml -inducible vector
Esophageal cancer cell line TE10 was cotransfected by Lipofectin (Gibco BRL) with pUHD15-1neo and pUHD10-3-GML at a 1 : 10 ratio (Furuhata et al., 1996; Gossen and Bujard 1992) . Stable cells were selected in medium containing geneticin (300 mg/ml) and doxycycline (2 ng/ml). Inducible expression of gml was con®rmed by RT ± PCR, 24 h after withdrawal of doxycycline (Furuhata et al., 1996) . We selected TE10-GML1 and TE10-GML2, which exhibited a tenfold increase in gml expression after 24 h of culture without doxycycline. TE10-vector was established as a control cell line using pUHD10-3 instead of pUHD10-3-GML.
Assay for proliferation of serum-starved cells TE10 was cultured in a complete medium (RPMI-1640 supplemented with 10% FBS). TE10-GML1 and TE10-vector were maintained in complete medium containing 50 mg/ml of geneticin and 2 ng/ml of doxycycline, as described previously (Furuhata et al., 1996) . TE10-GML1, TE10-vector and TE10 were seeded at 1.2610 5 in a 6-cm dish. The complete medium was replaced with medium supplemented respectively with 10% or 0.5% FBS in the absence of doxycycline. Cells in each culture were counted every 2 days for a period of 8 days. Cells were harvested on day 2 for analysis of the cell-cycle distribution by¯ow cytometry according to the procedure described below.
Cell survival and cell-cycle distribution under Taxol treatment
Cells were plated at a density of 1.0-1.5610 4 cells/cm 2 in a 6-cm dish. Twelve h later, fresh medium containing Taxol was added to cells to achieve desired concentrations (3 or 10 nM). Cells were counted in a hemocytometer, following trypsinization, 24, 48 and 72 h after treatment with Taxol. Three independent experiments were performed. Samples for analysis by¯ow cytometry were also harvested at the indicated time points.
Apoptotic features of tumor cells treated with Taxol
Tumor cells were stained with DAPI (4',6'-diamidine-2'-phenylindole dihydrochloride, Boehringer Mannheim), according to the manufacturer's instructions. Five hundred cells were counted under u.v.-¯uorescence microscopy and scored for the incidence of apoptotic changes in chromatin (Wyllie et al., 1980a, b) . Each set of data from at least two independent experiments was plotted.
Flow cytometry
Propidium iodide staining (Sigma) was used to analyse the cycling characteristics of cellular populations. Cultured cells were trypsinized, washed once with PBS(7) and ®xed in 70% ethanol at 7208C. Cells were stained with 50 mg/ml of propidium iodide after RNase treatment for 30 min at 378C, and analysed by FACScan (Becton Dickinson). The cell-cycle distribution was calculated using the manufacturer's Cell Fit program.
